Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
104,507,907
-
Share change
-
+816,931
-
Total reported value
-
$1,500,773,196
-
Put/Call ratio
-
173%
-
Price per share
-
$14.36
-
Number of holders
-
270
-
Value change
-
-$41,937,351
-
Number of buys
-
129
-
Number of sells
-
138
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q4 2024
As of 31 Dec 2024,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
270 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,507,907 shares.
The largest 10 holders included
FMR LLC, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock, Inc., Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., MORGAN STANLEY, RA CAPITAL MANAGEMENT, L.P., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, and CITADEL ADVISORS LLC.
This page lists
271
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.